TABLE 3.
Strain/constructs | Naf (1 μg/ml) | Tet (30 μg/ml) | Ery (10 μg/ml) | Nov (5 μg/ml) | Van (30 μg/ml) |
---|---|---|---|---|---|
TG1/pACYC | 20 | 35 | 31 | 27 | NI |
TG1/MtrE WT-CD | 12 | 25 | 20 | 19 | NI |
TG1/MtrE N198L-CD | 20 | 33 | 31 | 27 | 7 |
TG1/MtrE E434K-CD | 25 | 40 | 33 | 28 | NG |
TG1/MtrE Q441E-CD | 19 | 40 | 33 | 27 | NG |
TG1/MtrE R239E-CD | 14 | 29 | 27 | 25 | NI |
TG1/MtrE K397E-CD | 14 | 29 | 29 | 21 | NI |
KAM3/pET21a | 7 | 30 | 26 | 20 | NI |
KAM3/MtrE WT | NI | 26 | 21 | 15 | NI |
KAM3/MtrE N198L | NI | 26 | 21 | 15 | NI |
KAM3/MtrE E434K | NI | 26 | 21 | 15 | NI |
KAM3/MtrE Q441E | NI | 26 | 21 | 15 | NI |
KAM3/MtrE R239E | NI | 26 | 21 | 15 | NI |
KAM3/MtrE K397E | NI | 26 | 21 | 15 | NI |
KAM3 pACYC | 7 | 36 | 31 | 17 | NI |
KAM3/MtrE WT-C | 24 | 36 | 37 | 21 | 9 |
KAM3/MtrE N198L-C | NI | 26 | 21 | 15 | NI |
KAM3/MtrE E434K-C | NG | 50 | 40 | NG | NG |
KAM3/MtrE Q441E-C | NG | 36 | 37 | 21 | 27 |
KAM3/MtrE E434K-CD | 20 | 46 | 40 | 19 | 20 |
KAM3/MtrE WT-CD | NI | 27 | 21 | 10 | NI |